Global cancer statistics, 2012
Lindsey A. Torre,Freddie Bray,Rebecca L. Siegel,Jacques Ferlay,Joannie Lortet-Tieulent,Ahmedin Jemal +5 more
Reads0
Chats0
TLDR
A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.Abstract:
Cancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because of the growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns associated with urbanization and economic development. Based on GLOBOCAN estimates, about 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Over the years, the burden has shifted to less developed countries, which currently account for about 57% of cases and 65% of cancer deaths worldwide. Lung cancer is the leading cause of cancer death among males in both more and less developed countries, and has surpassed breast cancer as the leading cause of cancer death among females in more developed countries; breast cancer remains the leading cause of cancer death among females in less developed countries. Other leading causes of cancer death in more developed countries include colorectal cancer among males and females and prostate cancer among males. In less developed countries, liver and stomach cancer among males and cervical cancer among females are also leading causes of cancer death. Although incidence rates for all cancers combined are nearly twice as high in more developed than in less developed countries in both males and females, mortality rates are only 8% to 15% higher in more developed countries. This disparity reflects regional differences in the mix of cancers, which is affected by risk factors and detection practices, and/or the availability of treatment. Risk factors associated with the leading causes of cancer death include tobacco use (lung, colorectal, stomach, and liver cancer), overweight/obesity and physical inactivity (breast and colorectal cancer), and infection (liver, stomach, and cervical cancer). A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.read more
Citations
More filters
Journal ArticleDOI
Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta-analysis
Yi Zhao,Jingting Liu,Xiuyu Cai,Zhenkui Pan,Jun Liu,Weiqiang Yin,Hanzhang Chen,Zhanhong Xie,Hengrui Liang,Wei Wang,Zhihua Guo,Shen Zhao,Wenhua Liang,Jianxing He +13 more
TL;DR: Results indicate that osimertinib and gefitinib plus pemetrexed based chemotherapy were associated with the best progression free survival and overall survival benefits for patients with advanced EGFR mutated NSCLC, compared with other first line treatments.
Journal ArticleDOI
MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/ Akt/mTOR pathway
Qing-yong Chen,Demin Jiao,Yu-quan Wu,Jun Chen,Jing Wang,Xiali Tang,Hao Mou,Huizhen Hu,Jia Song,Jie Yan,Li-jun Wu,Jianyan Chen,Zhiwei Wang,Zhiwei Wang +13 more
TL;DR: It is found that hepatocyte growth factor induces EMT, invasion and migration in A549 and 95D lung cancer cells, and miR-206 could be a potential target for the therapeutic strategy against EMT and angiogenesis of lung cancer.
Journal ArticleDOI
Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPK.
TL;DR: The findings suggest that resveratrol inhibited proliferation but induced apoptosis and autophagy via inhibiting Akt/mTOR and activating p38-MAPK pathway and may act as a protective mechanism to promote NSCLC cell survival.
Journal ArticleDOI
Berberine may rescue Fusobacterium nucleatum -induced colorectal tumorigenesis by modulating the tumor microenvironment
Ya-Nan Yu,TaChung Yu,Hui-Jun Zhao,Tian-Tian Sun,Huimin Chen,Haoyan Chen,Hui-Fang An,Yu-Rong Weng,Jun Yu,Min Li,Wen-Xin Qin,Xiong Ma,Nan Shen,Jie Hong,Jing-Yuan Fang +14 more
TL;DR: F.ucleatum colonization in the intestine may prompt colorectal tumorigenesis, and BBR could rescue F. nucleatum-induced coloreCTal tumorsigenesis by modulating the tumor microenvironment and blocking the activation of tumorigenisation-related pathways.
Journal ArticleDOI
Human umbilical cord mesenchymal stem cell-derived extracellular vesicles promote lung adenocarcinoma growth by transferring miR-410
Liyang Dong,Yanan Pu,Lina Zhang,Qianqian Qi,Lei Xu,Wei Li,Chuan Wei,Xiaofan Wang,Sha Zhou,Jifeng Zhu,Xuefeng Wang,Feng Liu,Xiaojun Chen,Chuan Su +13 more
TL;DR: It is demonstrated for the first time that human umbilical cord MSCs dramatically increased the growth of lung adenocarcinoma (LUAD) cancer cells in a xenograft tumor model and it is observed that hUCMSC-derived extracellular vesicles (hUCMSS-EVs) contribute to the hUC MSCs-promoted LUAD cell growth through a direct effect on LUAD cells.
References
More filters
Journal ArticleDOI
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay,Isabelle Soerjomataram,Rajesh Dikshit,Sultan Eser,Colin Mathers,Marise Souto Rebelo,Donald Maxwell Parkin,David Forman,Freddie Bray +8 more
TL;DR: The GLOBOCAN series of the International Agency for Research on Cancer (IARC) as mentioned in this paper provides estimates of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012.
Journal ArticleDOI
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
TL;DR: This timely monograph is a distillation of knowledge of hepatitis B, C and D, based on a review of 1000 studies by a small group of scientists, and it is concluded that hepatitis D virus cannot be classified as a human carcinogen.
Book
Cancer Incidence in Five Continents
Freddie Bray,J. Ferlay,Mathieu Laversanne,David H. Brewster,C. Gombe Mbalawa,B. Kohler,Marion Piñeros,Eva Steliarova-Foucher,Rajaraman Swaminathan,Sebastien Antoni,Isabelle Soerjomataram,David Forman +11 more
TL;DR: The aim of this study was to establish a database of histological groups and to provide a level of consistency and quality of data that could be applied in the design of future registries.
Journal ArticleDOI
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R. Aberle,Amanda M. Adams,Christine D. Berg,William C. Black,Jonathan D. Clapp,Richard M. Fagerstrom,Ilana F. Gareen,Constantine Gatsonis,Pamela M. Marcus,JoRean D. Sicks +9 more
TL;DR: Screening with the use of low-dose CT reduces mortality from lung cancer, as compared with the radiography group, and the rate of death from any cause was reduced.